Vast Therapeutics
Durham · Founded 2017
About Vast Therapeutics
Vast Therapeutics develops inhalable treatments for antibiotic-resistant pathogens present in cystic fibrosis and other respiratory disease patients. The company is in the preclinical stage of developing inhalable therapeutics to treat chronic infections common to the cystic fibrosis population.
Company Facts
- Founded: 2017
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $18.8M
- Funding stage: Early Stage Venture
- Last round: Grant (Sep 2025)
- Website: http://vasttherapeutics.com/
- Phone: 919-321-1375
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/vast-therapeutics-48256 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.